510(k) device
Qb Test
Qbtech AB · Recorder, Attention Task Performance (LQD, Unclassified) · First FDA decision Mar 24, 2014, newest Mar 24, 2014ADHD
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
6
Naming "Qb"
MAUDE reports
0
Brand "Qb", since 2015
PubMed studies
2,855
Mentioning "Qb"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Qb Test
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- QB TEST510(k)
K133382 · Decided Mar 24, 2014 · 140 days after receipt
Device type: Recorder, Attention Task Performance (LQD) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLocal determinationIn effectL36485CGS Administrators, LLCUpdated Jul 8, 2026
- MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLocal determinationIn effectL36551Noridian Healthcare Solutions, LLCUpdated Jan 12, 2026
- MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLocal determinationIn effectL37003WPS Insurance CorporationUpdated Aug 23, 2023
- MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLocal determinationIn effectL36464Palmetto GBAUpdated Aug 16, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Qb", any status and sponsor, newest update first.
- Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal DiseaseCompleted
Mozarc Medical US LLCNot on our public-company list
NCT04395131 · 20 participants · Start Apr 3, 2020 · Primary completion Aug 14, 2020
Device: Clearum HF Hemodialyzer · For: End-stage Renal Disease
Sites: Düsseldorf, Germany
- Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line in Treatments of Patients With End-Stage Renal Disease (ESRD)Pivotal-lookingCompleted
Vantive Health LLCNot on our public-company list
NCT03859830 · 276 participants · Start Jan 22, 2019 · Primary completion Nov 9, 2019
Device: Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line; AK200 Ultra S, extracorporeal circulation conduct of blood purification · For: End-Stage Renal Disease
Sites: Beijing, China; Foshan, China; Wuhan, China · 7 sites in all
University Hospital, GhentAcademic, hospital or other
NCT01913977 · 4 participants · Start Feb 20, 2014 · Primary completion Jun 13, 2014
Device: Abylcap® System: blood flow (QB): 200mL/min; gas flow (QG):7L/min; Abylcap® System: blood flow (QB): 300mL/min; gas flow (QG):7L/min and 5 more · For: ARDS (Acute Respiratory Distress Syndrome); Respiratory Acidosis
Sites: Ghent, Belgium
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Qb", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LQD
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Qb"[tiab]. The summary above synthesizes these.
- Quantum brachistochrone.
Koike T · Philos Trans A Math Phys Eng Sci · 2022Review
- Versatile function of NF-B in inflammation and cancer.
Ma Q, Hao S, Hong W, et al. · Exp Hematol Oncol · 2024Review
- The NF-B p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth.
Kravtsova-Ivantsiv Y, Goldhirsh G, Tomuleasa C, et al. · Cancer Cell Int · 2023Review
- Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells.
Guo X, Fan A, Qi X, et al. · Bioorg Chem · 2023Research Support, Non-U.S. Gov't
- Efficient fusion requires a membrane anchor on the vacuolar Qa-SNARE.
Wickner W, Lopes K, Song H, et al. · Mol Biol Cell · 2023Research Support, N.I.H., Extramural
- Aurora-A/NF-B Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma.
Liu JB, Hu L, Yang Z, et al. · Anticancer Res · 2019
- TLR4 /NF-B and JAK2/STAT3 signaling pathways: Cellular signaling pathways targeted by cell-conditioned medium therapy in protection against ischemic stroke.
Nazarinia D, Dolatshahi M, Faezi M, et al. · J Chem Neuroanat · 2021Research Support, Non-U.S. Gov't
- Impact of Phytase Supplementation on Meat Quality of Heat-Stressed Broilers.
Maynard CJ, Maynard CW, Mullenix GJ, et al. · Animals (Basel) · 2023
- Self-Discharging Mitigated Quantum Battery.
Song WL, Wang JL, Zhou B, et al. · Phys Rev Lett · 2025
- Qb test improves diagnosis of attention deficit disorder.
Cole E · Nurs Child Young People · 2015
- Retinoic acid attenuates nuclear factor kappaB mediated induction of NLRP3 inflammasome.
Purbasari B, Madhyastha R, Madhyastha H, et al. · Pharmacol Rep · 2022
- BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer.
Śmiaek-Bartyzel J, Bzowska M, Mwżyk-Kopek R, et al. · Inflamm Res · 2023
Other devices of this type
Also filed under product code LQD.
- Test of Variables of Attention (T.O.V.A.)The Tova Company · 510(k) 2018
- QbCheckQbtech AB · 510(k) 2016
- DanaAnthrotronix, Inc. · 510(k) 2014
- QbtesQbtech AB · 510(k) 2012
- QbtestQbtech AB · 510(k) 2004
- Optax SystemOptax Systems, Inc. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.